Analystreport

Mateon Therapeutics Inc (NASDAQ: MATN) had its "hold" rating re-affirmed by analysts at Maxim Group.

MATEON THERAPEUTICS  (MATN) 
Last mateon therapeutics earnings: 11/19 05:25 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.mateon.com